An investigation by the I-Team revealed that nonprofit hospitals in Massachusetts aren't helping patients entitled to ...

Q1 2025 Earnings Call Transcript May 13, 2025 Biodesix, Inc. reports earnings inline with expectations. Reported EPS is ...

Details of Blue Shield-assigned member account numbers, claim service dates and service providers, patient names, and patients’ financial responsibility were also shared. Per a legally required ...

ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in ...

RIZE enrollment on track including U.S. sites and expected to be completed in May 2025; topline data anticipated in December 2025 U.S. F ...

Additional information regarding these results and other relevant information is included in the notes to the financial statements in “Item 18. Financial Statements”, which are included in InflaRx’s ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

patient financial responsibility; and “Find a Doctor” search criteria and results (such as location, plan name and type, provider name and type). There was no disclosure of other types of ...

Welcome to the Conference Call hosted by Daré Bioscience to review the company's First Quarter 2025 Financial Results and to provide the Business Update. This call is being recorded. My name is Gayle ...

First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer's Disease Six Month Interim Results Expected in 1H 2026 Topline Results Anticipated by end of 2026 CAMBRIDGE, Massachusetts ...